These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Barazzone C; Donati YR; Rochat AF; Vesin C; Kan CD; Pache JC; Piguet PF Am J Pathol; 1999 May; 154(5):1479-87. PubMed ID: 10329601 [TBL] [Abstract][Full Text] [Related]
8. Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation. Verbrugge SJ; Sorm V; van 't Veen A; Mouton JW; Gommers D; Lachmann B Intensive Care Med; 1998 Feb; 24(2):172-7. PubMed ID: 9539077 [TBL] [Abstract][Full Text] [Related]
9. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Hallman M; Merritt TA; Bry K Clin Pharmacokinet; 1994 Mar; 26(3):215-32. PubMed ID: 8194284 [TBL] [Abstract][Full Text] [Related]
10. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS). Hartog A; Gommers D; Lachmann B Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Lachmann B; Eijking EP; So KL; Gommers D Intensive Care Med; 1994; 20(1):6-11. PubMed ID: 8163763 [TBL] [Abstract][Full Text] [Related]
12. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Häfner D; Germann PG; Hauschke D Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777 [TBL] [Abstract][Full Text] [Related]
13. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS). Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456 [TBL] [Abstract][Full Text] [Related]
14. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Gommers D; Vilstrup C; Bos JA; Larsson A; Werner O; Hannappel E; Lachmann B Crit Care Med; 1993 Apr; 21(4):567-74. PubMed ID: 8472578 [TBL] [Abstract][Full Text] [Related]